Cretinism medical therapy

Revision as of 20:38, 27 October 2017 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search

Cretinism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cretinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cretinism medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cretinism medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cretinism medical therapy

CDC on Cretinism medical therapy

Cretinism medical therapy in the news

Blogs on Cretinism medical therapy

Directions to Hospitals Treating Cretinism

Risk calculators and risk factors for Cretinism medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The mainstay of treatment for cretinism is thyroid hormone replacement therapy. levothyroxine (L-T4) is administrated orally to patients with cretinism.

Medical Therapy

  • Patients with cretinism are treated with thyroid hormone replacement therapy.
  • Endocrine society recommended with the appropriate quick initiation of levothyroxine as the mainstay treatment of cretinism.[1]
  • levothyroxine:
    • Life long synthetic levothyroxine (L-T4) is used to treat the cretinism.
    • Preferred regimen:  10–15 μg/kg per day orally.

References

  1. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G; et al. (2014). "European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism". J Clin Endocrinol Metab. 99 (2): 363–84. doi:10.1210/jc.2013-1891. PMC 4207909. PMID 24446653.

Template:WH Template:WS ​​​